Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
- MasterCard (MA) Approves $3.5B Buyback; Announces 10-for-1 Split, 83% Dividend Increase
- Costco Wholesale (COST) Misses Q1 EPS by 7c; adj.-Comps Up 5%
- Bernanke Could Put In Motion Plans to End the QE-Monster He Created - Nomura
- Pope Francis Named TIME's 2013 Person of the Year
- After Hours Stock Movers 12/10: (SNI) (SWHC) (MA) Higher; (AVNR) (LH) (BBRY) Lower (more...)
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
You May Also Be Interested In
- Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference
- Exa (EXA) Files $75M Common Stock Shelf
- Yandex (YNDX) Announces $600M Convertible Notes Offering; Adds 3M to Buyback Plan
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!